KLAS Research U.S. Digital Pathology Report Confirms Philips As One of The Industry’s Leading Players

Read the KLAS Research ‘US Digital Pathology 2023’ Performance Insights report. Philips has helped more than 300 customers transition to a fully digital workflow, with many more using Philips IntelliSite Pathology solution as an open platform for primary diagnosis The first company to introduce an FDA-approved digital pathology slide scanner for primary diagnostic use in 2017, Philips is one…

Read More

Pan-Cancer Study Reveals Epigenomic Drivers for Cancer Development and Progression

A team of researchers have identified epigenomic drivers associated with cancer development and progression, constructing a pan-cancer epigenetic and transcriptomic atlas from the data. This atlas “provides a foundation for further investigation of epigenetic dynamics in cancer transitions,” the study team, led by researchers from Washington University in St. Louis, wrote in Nature. The researchers used…

Read More

National Cancer Plan

https://nationalcancerplan.cancer.gov/ We know that our continued progress against cancer is the direct result of advances made possible by investment from federal, state, and local governments, along with private investment, and by the sustained efforts of researchers around the world and millions of people with cancer, their caregivers, and advocates. Building on these tremendous efforts and…

Read More

Precision for Medicine – Biobank Partnering for Clinical Trial Assay/CDx Development and High-throughput IHC & NGS Screening

On March 7, 2023, Robert Snyder, PhD, Associate Director of Genomics at Precision for Medicine, delivered a presentation entitled, Biobank Partnering for Clinical Trial Assay / CDx Development and High-throughput IHC & NGS Screening, at the 30th International Molecular Med Tri-Con Conference & Expo. As an end-to-end provider of biospecimens, specialty labs, and regulatory consulting services, Precision for…

Read More

Qvin™ Diagnostic Device Receives FDA Approval in Thailand

SAN FRANCISCO, Feb. 2, 2023 /PRNewswire/ — Qvin™, the biotechnology company that developed the first and only healthcare service that scientifically collects menstrual blood to test for HR-HPV and other critical healthcare information, announced FDA approval in Thailand for its Q-Pad technology. Thailand has a population of 30 million women ages 15 years and older who are at risk of developing cervical…

Read More

Fred Hutchinson Cancer Research Center Specimen Acquisition Network (SAN) – Specimen and Data Acquisition Network Services Now Available to the University of Washington (UW) Institute of Translation Health Sciences (ITHS) Community

January 27, 2022 – The Specimen Acquisition Network (SAN) was founded in 2019 when Fred Hutch reached out to academic centers across the Pacific Northwest region, spanning from British Columbia to Portland – leveraging connections through the Cascadia Data Alliance – to increase access to and awareness of available resources, share ideas and foster partnerships,…

Read More

Autism-Related Dietary Preferences Mediate Autism-Gut Microbiome Associations

Published:November 11, 2021DOI:https://doi.org/10.1016/j.cell.2021.10.015 Highlights Summary There is increasing interest in the potential contribution of the gut microbiome to autism spectrum disorder (ASD). However, previous studies have been underpowered and have not been designed to address potential confounding factors in a comprehensive way. We performed a large autism stool metagenomics study (n = 247) based on participants…

Read More

Could the Gut Microbiome be Linked to Autism?

Researchers are hoping to understand whether the microbes in our guts have a role in the disorder. Before Ethan Loyola reached his first birthday, it was clear that something was wrong with his gut. As a baby, he had been given several courses of antibiotics to treat severe ear infections, after which he experienced foul-smelling,…

Read More

A Biospecimen Crisis in Biotech?

All crises are not equal, but they all need to be recognised, says Robert Hewitt Robert Hewitt is the founder of Biosample Hub, a new platform that connects biotech companies looking for samples with biobanks that have ethically sourced samples available A dictionary definition of a crisis is a time of great difficulty or danger…

Read More